These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 27595792

  • 1. Functional Properties of Human Cytomegalovirus Hyperimmunoglobulin and Standard Immunoglobulin Preparations.
    Germer M, Herbener P, Schüttrumpf J.
    Ann Transplant; 2016 Sep 06; 21():558-64. PubMed ID: 27595792
    [Abstract] [Full Text] [Related]

  • 2. Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: Impact of CMV IgG normalization.
    Schampera MS, Schweinzer K, Abele H, Kagan KO, Klein R, Rettig I, Jahn G, Hamprecht K.
    J Clin Virol; 2017 May 06; 90():40-45. PubMed ID: 28342316
    [Abstract] [Full Text] [Related]

  • 3. In vitro evaluation of cytomegalovirus-specific hyperimmune globulins vs. standard intravenous immunoglobulins.
    Miescher SM, Huber TM, Kühne M, Lieby P, Snydman DR, Vensak JL, Berger M.
    Vox Sang; 2015 Jul 06; 109(1):71-8. PubMed ID: 25766313
    [Abstract] [Full Text] [Related]

  • 4. Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations.
    Planitzer CB, Saemann MD, Gajek H, Farcet MR, Kreil TR.
    Transplantation; 2011 Aug 15; 92(3):267-70. PubMed ID: 21659947
    [Abstract] [Full Text] [Related]

  • 5. Role of pentamer complex-specific and IgG subclass 3 antibodies in HCMV hyperimmunoglobulin and standard intravenous IgG preparations.
    Schampera MS, Arellano-Galindo J, Kagan KO, Adler SP, Jahn G, Hamprecht K.
    Med Microbiol Immunol; 2019 Feb 15; 208(1):69-80. PubMed ID: 30203132
    [Abstract] [Full Text] [Related]

  • 6. Relative EBV antibody concentrations and cost of standard IVIG and CMV-IVIG for PTLD prophylaxis in solid organ transplant patients.
    Ramirez-Avila L, Garner OB, Cherry JD.
    Pediatr Transplant; 2014 Sep 15; 18(6):599-601. PubMed ID: 25041939
    [Abstract] [Full Text] [Related]

  • 7. Measurement and assessment of cytomegalovirus of immunoglobulin (Ig) g titer in preparations.
    Shibaguchi H, Yamamoto T, Kuroki M, Futagami K.
    Yakugaku Zasshi; 2010 Jul 15; 130(7):977-82. PubMed ID: 20606378
    [Abstract] [Full Text] [Related]

  • 8. Functional differences between antiviral activities of sulfonated and intact intravenous immunoglobulin preparations toward varicella-zoster virus and cytomegalovirus.
    Yajima M, Shiraki A, Daikoku T, Oyama Y, Yoshida Y, Shiraki K.
    J Infect Chemother; 2015 Jun 15; 21(6):427-33. PubMed ID: 25824903
    [Abstract] [Full Text] [Related]

  • 9. Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease.
    Nigro G.
    Expert Rev Anti Infect Ther; 2017 Nov 15; 15(11):977-986. PubMed ID: 29072089
    [Abstract] [Full Text] [Related]

  • 10. Immunomodulation by hyperimmunoglobulins after solid organ transplantation: Beyond prevention of viral infection.
    van Gent R, Metselaar HJ, Kwekkeboom J.
    Transplant Rev (Orlando); 2017 Apr 15; 31(2):78-86. PubMed ID: 28131494
    [Abstract] [Full Text] [Related]

  • 11. Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study.
    Kagan KO, Enders M, Hoopmann M, Geipel A, Simonini C, Berg C, Gottschalk I, Faschingbauer F, Schneider MO, Ganzenmueller T, Hamprecht K.
    Ultrasound Obstet Gynecol; 2021 Apr 15; 57(4):560-567. PubMed ID: 33491819
    [Abstract] [Full Text] [Related]

  • 12. Binding and neutralizing anti-cytomegalovirus activities in immune globulin products.
    Wang X, Xu Y, Scott DE, Murata H, Struble EB.
    Biologicals; 2017 Nov 15; 50():35-41. PubMed ID: 29029807
    [Abstract] [Full Text] [Related]

  • 13. Interaction of Immunoglobulin with Cytomegalovirus-Infected Cells.
    Aiba N, Shiraki A, Yajima M, Oyama Y, Yoshida Y, Ohno A, Yamada H, Takemoto M, Daikoku T, Shiraki K.
    Viral Immunol; 2017 Sep 15; 30(7):500-507. PubMed ID: 28598267
    [Abstract] [Full Text] [Related]

  • 14. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
    Kagan KO, Enders M, Schampera MS, Baeumel E, Hoopmann M, Geipel A, Berg C, Goelz R, De Catte L, Wallwiener D, Brucker S, Adler SP, Jahn G, Hamprecht K.
    Ultrasound Obstet Gynecol; 2019 Mar 15; 53(3):383-389. PubMed ID: 29947159
    [Abstract] [Full Text] [Related]

  • 15. Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins.
    Chehimi J, Peppard J, Emanuel D.
    Bone Marrow Transplant; 1987 Dec 15; 2(4):395-402. PubMed ID: 2844341
    [Abstract] [Full Text] [Related]

  • 16. Circulating cytomegalovirus (CMV) neutralizing activity in bone marrow transplant recipients: comparison of passive immunity in a randomized study of four intravenous IgG products administered to CMV-seronegative patients.
    Filipovich AH, Peltier MH, Bechtel MK, Dirksen CL, Strauss SA, Englund JA.
    Blood; 1992 Nov 15; 80(10):2656-60. PubMed ID: 1330079
    [Abstract] [Full Text] [Related]

  • 17. The importance of cytomegalovirus-specific antibodies for the prevention of fetal cytomegalovirus infection or disease.
    Adler SP, Nigro G.
    Herpes; 2008 Nov 15; 15(2):24-7. PubMed ID: 19856544
    [Abstract] [Full Text] [Related]

  • 18. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study.
    Fleming JN, Taber DJ, Weimert NA, Nadig S, McGillicuddy JW, Bratton CF, Baliga PK, Chavin KD.
    Transpl Infect Dis; 2017 Dec 15; 19(6):. PubMed ID: 28921781
    [Abstract] [Full Text] [Related]

  • 19. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.
    Blázquez-Gamero D, Galindo Izquierdo A, Del Rosal T, Baquero-Artigao F, Izquierdo Méndez N, Soriano-Ramos M, Rojo Conejo P, González-Tomé MI, García-Burguillo A, Pérez Pérez N, Sánchez V, Ramos-Amador JT, De la Calle M.
    J Matern Fetal Neonatal Med; 2019 Feb 15; 32(4):617-625. PubMed ID: 28978246
    [Abstract] [Full Text] [Related]

  • 20. Serum concentrations of immunoglobulins and of antibody isotypes in bone marrow transplant recipients treated with high doses of polyspecific immunoglobulin or with cytomegalovirus hyperimmune globulin.
    Gratwohl A, Doran JE, Bachmann P, Scherz R, Späth P, Baumgartner C, Perret B, Berger C, Nissen C, Tichelli A.
    Bone Marrow Transplant; 1991 Oct 15; 8(4):275-82. PubMed ID: 1661632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.